Loading data for FEMY — first visit, this takes a few seconds.

Preisalarm

Femasys Inc. (FEMY)

NasdaqCM: FEMY · Echtzeitkurs · USD

2.16

-0.13 (-5.68%)

Zum Schluss: Aug 17, 2026, 8:00 PM

-5.68% (1D)

Keine Daten verfügbar

Geld	1.63
Marktkapitalisierung	17.35 Mio
Umsatz (TTM)	2.3 Mio
Nettogewinn (TTM)	-11.77 Mio
Beta	n/a
EPS (ttm)	-4.53
KGV (TTM)	n/a
Forward-KGV	-0.49
KBV (TTM)	0.89
KUV (TTM)	7.55
Earnings Date	n/a

Brief	2.58
Volumen	237,409
Ø Vol. (20D)	113,866
Eröffnung	2.28
Vortagesschluss	2.29
Tagesspanne	2.02 - 2.29
52-Wk Range	2.02 - 22.20
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über FEMY

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for c...

[Mehr lesen]

Branche Medical Instruments & Supplies

Sektor Healthcare

IPO Datum Jun 18, 2021

Mitarbeiter 51

Börse NasdaqCM

Tickersymbol FEMY

Website https://femasys.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Femasys 2.29 Mio, ein Anstieg von 40.77% im Vergleich zum Vorjahr (1.63 Mio). Der Gewinn lag bei -18.63 Mio, ein Rückgang von -1 %.

Finanzberichte

Gewinnüberraschung

Femasys hat die Quartalszahlen am Aug 14, 2026 veröffentlicht:

Umsatz von $424.89K verfehlt die Erwartungen um $0, mit 24.50% Wachstum im Jahresvergleich.

EPS von -1.1 übertrifft die Erwartungen um 0.30, mit 65.63% Wachstum im Jahresvergleich.

Nachrichten

vor 2 Monaten · Motley Fool

Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More

Innoviva develops respiratory pharmaceuticals through strategic partnerships and royalty agreements in the global healthcare market.

vor 9 Monaten · Associated Press Finance

BC-Most Active Stocks

td class="col-issue">New Era Energy & Digital Inc.

vor 10 Monaten · TipRanks

Femasys partners with Medical Electronic Systems for FemSperm kit

Femasys (FEMY) announced a partnership with Medical Electronic Systems to provide advanced sperm analysis technology. The FemSperm Analysis Kit completes the FemSperm product family, joining the Setup...

vor 11 Monaten · Insider Monkey

Femasys (FEMY) Falls 27% as Firm to Raise $8-Million from Share Sale

We recently published 10 Stocks Losing Big. Femasys Inc. (NASDAQ:FEMY) is one of the worst performers of Tuesday. Femasys extended losses to a second day on Tuesday, slashing 27 percent to close at $0...

vor 11 Monaten · MT Newswires

Femasys Prices $8 Million Public Offering; Shares Slump Pre-Bell

Femasys (FEMY) said late Monday it has priced its offering of shares and warrants, expecting about $